title: The riboflavin analog roseoflavin targets an FMN-riboswitch and blocks Listeria monocytogenes growth, but also stimulates virulence gene-expression and infection.
abstract: During recent years, riboswitches have emerged as potential targets for novel antibacterial substances. In this study, we investigated how one flavin analog, roseoflavin, affected the gene-expression, growth and infectivity of the human bacterial pathogen Listeria monocytogenes to determine the potential of this analog to function as an antibacterial substance. The results indicate that roseoflavin has a profound inhibiting effect on the growth of L. monocytogenes at very low concentrations. Also, expression of the gene located downstream of the FMN riboswitch, a riboflavin transporter, was blocked by the addition of roseoflavin. Base-substitution mutations in the FMN riboswitch allowed the bacteria to grow in the presence of roseoflavin, showing that roseoflavin targeted the FMN riboswitch directly. Surprisingly, we found that roseoflavin stimulated L. monocytogenes virulence gene expression and infection abilities in a mechanism independent of the FMN riboswitch. Our results suggest that roseoflavin can block growth but also enhance Listeria virulence.
authors: Department of Molecular Biology, Umeå University,  Umeå, Sweden.
authors: Mikael
authors: M
authors: Mansjö
authors: Jörgen
authors: J
authors: Johansson
references: Appl Environ Microbiol. 2004 Nov;70(11):6887-91
references: 15528558
references: Trends Genet. 1999 Nov;15(11):439-42
references: 10529804
references: Mol Microbiol. 1995 Nov;18(3):413-23
references: 8748026
references: Genetika. 2000 Aug;36(8):1166-8
references: 11033791
references: Vitam Horm. 2001;61:1-49
references: 11153262
references: Curr Opin Struct Biol. 2004 Jun;14(3):344-9
references: 15193315
references: Nat Rev Microbiol. 2010 Jun;8(6):401-12
references: 20453875
references: Appl Microbiol Biotechnol. 2006 Jul;71(3):265-75
references: 16607521
references: Int J Food Microbiol. 1997 Mar 18;35(1):91-5
references: 9081230
references: Annu Rev Microbiol. 2004;58:587-610
references: 15487949
references: Nat Rev Microbiol. 2009 Sep;7(9):623-8
references: 19648949
references: Cell. 2009 Nov 13;139(4):770-9
references: 19914169
references: Nucleic Acids Res. 2002 Jul 15;30(14):3141-51
references: 12136096
references: J Antibiot (Tokyo). 1974 Jan;27(1):86-7
references: 4843053
references: J Bacteriol. 2008 Aug;190(15):5412-30
references: 18502850
references: Mol Microbiol. 1994 Jun;12(5):845-53
references: 8052135
references: J Bacteriol. 2007 Oct;189(20):7367-75
references: 17693491
references: Mol Microbiol. 1993 Apr;8(2):219-27
references: 8316076
references: Curr Opin Pharmacol. 2010 Oct;10(5):551-6
references: 20685165
references: Nature. 2009 Jun 18;459(7249):950-6
references: 19448609
references: Infect Immun. 2000 Feb;68(2):999-1003
references: 10639481
references: RNA Biol. 2009 Apr-Jun;6(2):187-94
references: 19246992
references: BMC Bioinformatics. 2009 May 08;10:136
references: 19426475
references: Nature. 2009 Mar 12;458(7235):233-7
references: 19169240
references: RNA Biol. 2009 Jul-Aug;6(3):276-80
references: 19333008
references: Annu Rev Microbiol. 2005;59:487-517
references: 16153177
references: Proc Natl Acad Sci U S A. 2002 Dec 10;99(25):15908-13
references: 12456892
references: Nucleic Acids Res. 2005 Jan 1;33(Database issue):D121-4
references: 15608160
references: Nat Biotechnol. 2006 Dec;24(12):1558-64
references: 17160062
references: ACS Chem Biol. 2009 Nov 20;4(11):915-27
references: 19739679